Promethazine is a first-generation antihistamine with an unusually broad set of effects: it blocks histamine receptors to reduce allergy symptoms, acts on the brain’s vomiting center to control nausea, and produces enough sedation that it has been used as a pre-surgical calming agent for decades. That versatility has made it one of the most widely prescribed medications in emergency departments and clinics worldwide, but it also means the drug carries a longer list of side effects and risks than most people expect from something filed under “antihistamine.”
How Promethazine Works
Promethazine belongs to the phenothiazine chemical family, which also includes some antipsychotic medications. Its primary action is blocking the H1 histamine receptor, which is what reduces allergic reactions like itching, sneezing, and hives. But it does not stop there. Promethazine also blocks muscarinic acetylcholine receptors (responsible for many of its drying effects and some of its side effects) and weakly blocks dopamine receptors in the brain. That dopamine-blocking action is part of why it works so well against nausea but also why it can cause movement-related side effects that pure antihistamines generally do not.
Nausea and vomiting involve a surprisingly complicated network of signals. The brain’s chemoreceptor trigger zone and the vagus nerve communicate through multiple chemical messengers, including dopamine, serotonin, histamine, and acetylcholine. Because promethazine interferes with several of those messengers at once, it can suppress nausea through more than one pathway simultaneously.1SAGE Open Medicine. Moving beyond promethazine: Advancing precision in antiemetic therapy That multi-target approach is both its strength and, as we will see, the source of many of its complications.
What Promethazine Is Prescribed For
Emergency departments rely heavily on promethazine for treating nausea and vomiting, which are among the most common reasons people show up to the ER.2The Journal of Emergency Medicine. Promethazine: A Review of Therapeutic Uses and Toxicity Beyond that acute setting, promethazine is used for:
- Allergic reactions: hives, allergic rhinitis, and mild allergic responses where the sedation is either tolerable or desirable.
- Motion sickness: it remains a standard option for preventing seasickness and travel-related nausea.
- Sedation: as a pre-operative or pre-procedural sedative, especially in children, and as an adjunct to pain medications after surgery.
- Cough suppression: in combination products containing codeine, promethazine is prescribed for persistent cough.
Its effectiveness for motion sickness appears linked to how it alters the brain’s processing of body movement. Research has shown that promethazine raises the threshold at which people perceive tilting motion by roughly a third, which may explain why the vestibular mismatch that causes motion sickness becomes less bothersome under its influence.3MIT DSpace. The Impact of Oral Promethazine on Human Whole-Body Motion Perceptual Thresholds
How It Stacks Up Against Ondansetron
For nausea and vomiting specifically, the question many clinicians and patients face is whether promethazine is worth its side effects when alternatives exist. The most common comparison is with ondansetron (often known by the brand name Zofran), which blocks serotonin receptors rather than histamine and dopamine receptors.
In a randomized trial comparing the two drugs for undifferentiated nausea in the emergency department, both reduced nausea by a similar amount. But promethazine produced substantially more sedation. Patients given ondansetron reported almost no increase in drowsiness, while those given promethazine experienced a meaningful jump.4PubMed. Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double-blind, noninferiority trial Broader evidence reviews have echoed this finding: ondansetron matches promethazine for nausea control without the sedation or the risk of a specific movement side effect called akathisia, an intensely uncomfortable feeling of restlessness.5The Journal of Emergency Medicine. Evidence-Based Review of Antiemetics in the Emergency Department
That said, promethazine is not always the wrong choice. When a patient is agitated, in pain, and nauseated all at once, the sedation can be a feature rather than a bug. It is also cheaper and more widely available than ondansetron in some healthcare systems. The issue is not that promethazine should never be used but that it probably should not be the default when a less sedating option works equally well for nausea alone.
Side Effects and Their Mechanisms
Drowsiness is the side effect people notice first, and it is not subtle. Even at standard doses, self-perceived drowsiness increases significantly, and objective tests of neuromotor function confirm that motor skills degrade after taking promethazine, even at relatively low doses.6PubMed. Low dosage promethazine and loratadine negatively affect neuromotor function This is relevant for anyone who needs to drive, operate machinery, or stay alert after taking the drug. Second-generation antihistamines like loratadine were specifically developed to reduce this central sedation, though they lack the anti-nausea properties that make promethazine useful in the first place.
The anticholinergic effects are the next layer. By blocking acetylcholine receptors, promethazine causes dry mouth, blurred vision, constipation, urinary retention, and increased heart rate. These effects range from annoying to dangerous depending on the patient. For someone already taking other anticholinergic medications, stacking promethazine on top can produce a cumulative burden that clouds thinking and raises fall risk.
Then there are the movement disorders tied to dopamine receptor blockade. Promethazine can trigger dystonia (sustained involuntary muscle contractions), akathisia (a distressing inner restlessness), and, with prolonged use, tardive dyskinesia (repetitive involuntary movements, especially around the mouth and face).7PubMed Central. Acute onset of orofacial dystonia from promethazine treatment: A case report These reactions are uncommon but can be frightening when they occur, and dystonia in particular can happen after a single dose.
The IV Injection Problem
One of the most serious safety concerns with promethazine has nothing to do with its pharmacology and everything to do with how it is physically given. When injected into a vein, promethazine solution is highly caustic to blood vessel walls and surrounding tissue. Reports from multiple countries describe consequences including blood clots at the injection site, nerve damage, tissue death, and gangrene. In severe cases, patients have needed skin grafts or even amputation.8Medsafe. Intravenous Promethazine and Soft Tissue Injuries
The risk is highest when promethazine leaks out of the vein into surrounding tissue (a complication called extravasation) or when it is injected into a small hand or wrist vein rather than a larger one. Many hospitals have restricted or outright banned IV promethazine in favor of oral or intramuscular routes, or they require it to be diluted and given slowly through a large-bore IV in a big vein. If you are receiving promethazine by injection and feel burning at the IV site, that is worth mentioning immediately.
Risks for Older Adults
Anticholinergic medications as a class carry heightened risks for people over 65, including confusion, memory problems, falls, and delirium. Promethazine appears on lists of drugs to avoid in older adults compiled by multiple geriatric medicine organizations, yet prescribing data suggests it remains common. A national survey found that roughly one in four older adults with dementia were using a potentially inappropriate anticholinergic medication, and promethazine was among the most frequently prescribed.9Journal of the American Pharmacists Association. Prevalence and predictors of potentially inappropriate anticholinergic medication use in older adults with dementia The cognitive effects of these drugs in people who already have impaired brain function make this a real clinical concern, not just a theoretical one.
Promethazine During Pregnancy
Morning sickness is one of the earliest and most common complaints of pregnancy, so the safety of anti-nausea drugs for pregnant women matters enormously. Promethazine has been used for decades in early pregnancy, and a large population-based study looking specifically at birth outcomes found no evidence that standard clinical doses increased the rate of birth defects.10PubMed. A population-based case-control teratologic study of promethazine use during pregnancy That is reassuring, though as with any medication during pregnancy, the decision involves weighing benefits against the small residual uncertainty that any single study cannot entirely eliminate. Promethazine is generally considered an option for nausea in pregnancy when first-line treatments like vitamin B6 and doxylamine are not enough.
Misuse and “Purple Drank”
Promethazine has a recreational side that its medical uses might not immediately suggest. The combination of promethazine and codeine, sold as a prescription cough syrup, became the basis for a drink known as “purple drank” or “lean” when mixed with soda and sometimes hard candy. The practice gained visibility through hip-hop culture and has been linked to several high-profile deaths.11PubMed. “Purple Drank” (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications The codeine provides an opioid high while promethazine intensifies the sedation and euphoria and reduces the nausea that opioids can cause, making the combination feel smoother than codeine alone.
But promethazine misuse is not limited to this particular cocktail. European adverse drug reaction reports have documented promethazine abuse beyond the codeine combination, and the codeine-promethazine mixture itself carries genuine addiction risk because of the opioid component.12PubMed Central. Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports The danger is compounded by the fact that both codeine and promethazine suppress breathing. Together, especially with alcohol added to the mix, the risk of respiratory failure climbs steeply.
The Opioid Connection
Outside of recreational use, promethazine shows up surprisingly often alongside opioid prescriptions in clinical settings. A study of chronic pain patients found that about 9% had promethazine in their urine, and only half of those patients actually had a prescription for it, suggesting significant off-label or non-prescribed use. Patients on methadone, whether for pain or for opioid dependence treatment, were roughly two to three times more likely to test positive for promethazine. Those taking only a long-acting opioid were also about twice as likely to use promethazine compared to those on a short-acting opioid.13PubMed Central. Promethazine use among chronic pain patients
The pattern makes pharmacological sense. Opioids cause nausea, and promethazine treats nausea. Opioids cause itching, and promethazine is an antihistamine. Some patients may also seek the enhanced sedation that the combination produces. But the respiratory depression from combining these drugs is the elephant in the room. Clinicians who see promethazine in a patient’s drug screen alongside opioids they did not prescribe treat it as a red flag for potential misuse or at least for underappreciated risk.
What Happens in Overdose
Promethazine overdose looks different from what most people imagine for an antihistamine. The dominant feature is delirium, not simply extreme sleepiness. In a study of overdose cases, delirium occurred in about 42% of patients, and rapid heart rate showed up in more than half. Hypotension, seizures, dangerous heart rhythms, and deaths were rare to absent. The probability of developing delirium scaled with dose: roughly a 31% chance at 250 mg, 42% at 500 mg, and 55% at 1,000 mg of promethazine alone. Activated charcoal given within two hours reduced the likelihood of delirium, and co-ingestion of other substances also affected outcomes.14QJM. Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal
The anticholinergic nature of promethazine explains the clinical picture. Delirium from anticholinergic overdose is often described as “mad as a hatter” in medical shorthand: agitation, confusion, hallucinations, hot dry skin, dilated pupils, and a racing heart. This is distinct from opioid overdose, where the patient becomes sedated and stops breathing. In a mixed overdose involving both promethazine and an opioid, the clinical picture can be confusing because the stimulating anticholinergic effects and the depressing opioid effects partially mask each other, making it harder to gauge severity.
Individual Variation in How Promethazine Is Processed
Your body breaks down promethazine primarily through an enzyme called CYP2D6 in the liver.15PubMed. CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes This matters because CYP2D6 activity varies widely between people based on their genetics. A small percentage of the population metabolizes drugs through this enzyme very slowly, meaning a standard dose of promethazine stays in their system longer and hits harder. Others metabolize it so quickly that a standard dose may wear off faster than expected. These differences are one reason the same dose of promethazine can leave one person barely drowsy and another essentially unable to function.
CYP2D6 is also the enzyme responsible for converting codeine into its active form, morphine. In people who are ultra-rapid metabolizers, codeine-promethazine cough syrup can produce dangerously high morphine levels even at prescribed doses. This pharmacogenetic wrinkle adds another layer of risk to the codeine-promethazine combination, particularly in children, where several deaths prompted the FDA to restrict codeine use in pediatric patients.
Promethazine as an Environmental Pollutant
Pharmaceuticals that pass through our bodies and into wastewater do not simply vanish, and promethazine is among the drugs turning up in rivers and coastal waters. Even at low concentrations, promethazine in aquatic environments affects the organisms living there. Laboratory studies on tiny crustaceans (Daphnia and brine shrimp) and zebrafish have shown that exposure to promethazine at microgram-per-liter levels can alter larval development and reduce swimming activity in fish larvae, suggesting disruption of neurological signaling pathways that are broadly shared across animal species.16Environmental Toxicology and Chemistry. Enantioselective ecotoxicity of promethazine in two freshwater organisms: daphnia (Daphnia magna) and zebrafish (Danio rerio)
In brine shrimp, exposure to promethazine appeared to accelerate larval development, pushing organisms through molting stages faster than normal, a finding that echoes similar observations with other first-generation antihistamines in small aquatic invertebrates.17PubMed Central. Acute Toxicity of a Marine Emerging Pollutant (Promethazine Hydrochloride) on Artemia sp The concentrations used in these studies are typically higher than what is found in real waterways today, but the direction of the findings underscores a broader concern about the ecological footprint of widely used medications. Wastewater treatment plants were not designed to remove pharmaceuticals, and as global medication use increases, the cumulative effect on aquatic ecosystems is an area of active research with few clean answers yet.